在阿尔茨海默病中APOE4的细胞类型特定作用
Jessica Blumenfeld1,2, Oscar Yip1,3, Min Joo Kim1,3
1Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Nature reviews. Neuroscience
|January 8, 2024
概括
APOE4基因变异是一种主要的阿尔茨海默氏症风险因素. 新的研究揭示了APOE4在不同脑细胞中的特定作用,突出显示神经元APOE4是阿尔茨海默病进展的关键驱动因素.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 无脂蛋白E基因的e4等位基因 (APOE4) 是晚发性阿尔茨海默病 (AD) 的主要遗传风险因素.
- 了解APOE4在不同中枢神经系统 (CNS) 细胞类型中的多样性功能,对于阐明AD病原性至关重要.
- 研究APOE4的细胞特异性作用是具有挑战性的,因为它在不同的条件下由各种细胞类型产生.
研究的目的:
- 在细胞类型特定水平上审查研究APOE4在阿尔茨海默病 (AD) 中的作用的最新进展.
- 提出一种新的细胞类型特定的APOE4级联模型,用于AD的发病.
- 为未来的研究方向和治疗APOE4相关AD的发展提供视角.
主要方法:
- 利用尖端的奥米学研究,包括单细胞分析.
- 使用新型细胞培养和动物模型进行有针对性的研究.
- 审查有关APOE4在各种中枢神经系统细胞类型中的功能现有的科学文献.
主要成果:
- 根据产生的中枢神经系统细胞类型 (星细胞,神经元,微质细胞,寡细胞,血管细胞) APOE4 具有不同的病理效应.
- 单细胞水平的研究已经确定了AD-易受伤害的细胞亚型中的关键APOE4效应.
- 神经元APOE4被确定为AD病变发生的关键发起者和驱动者,触发下游的质反应.
结论:
- 一种特定于细胞类型的APOE4级联模型表明,神经元APOE4启动AD病理,导致神经退行.
- 针对细胞特异性APOE4功能,为阿尔茨海默病提供了潜在的治疗策略.
- 对APOE4多样化的细胞作用的进一步研究对于开发有效的AD治疗是必不可少的.
相关概念视频
01:26Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
02:23RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K